Transcript level of nucleostemin in newly diagnosed acute myeloid leukemia patients

被引：6

作者：

You, Yong ^{[1
]}

Li, Xiaoqing ^{[2
]}

Zheng, Jine ^{[2
]}

Wu, Yaohui ^{[1
]}

He, Yanli ^{[2
]}

Du, Wen ^{[2
]}

Zou, Ping ^{[1
]}

Zhang, Min ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan 430022, Hubei Province, Peoples R China

[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Stem Cell Res & Applicat,Inst Hematol, Wuhan 430022, Hubei Province, Peoples R China

来源：

LEUKEMIA RESEARCH | 2013年 / 37卷 / 12期

关键词：

Nucleostemin; Acute myeloid leukemia; Risk stratification; Minimal residual disease; MINIMAL RESIDUAL DISEASE; ACUTE MYELOGENOUS LEUKEMIA; POLYMERASE-CHAIN-REACTION; TUMOR-INITIATING CELLS; GENE-MUTATIONS; NORMAL KARYOTYPE; AML PATIENTS; STEM-CELLS; EXPRESSION; WT1;

D O I：

10.1016/j.leukres.2013.09.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To clarify the role of nucleostemin (NS) in AML, its transcription levels in bone marrow (BM) samples obtained from 128 newly diagnosed AML patients were analyzed. We determined that the highest NS transcription level was in M1 patients, while the lowest NS transcription level was in M3 patients. NS mRNA expression is positively correlated with blast percentages (%) and CD34, CD117 and CD123 antigen expression in BM samples but is unrelated to the transcription level of WTI. A significant difference in NS expression between poor-risk and better-risk and between poor-risk and intermediate-risk AML patients was found. Our initial data indicated that NS can be used for tracking minimal residual disease (MRD) and is a helpful guide for treatment. (C) 2013 Elsevier Ltd. All rights reserved.

引用

收藏

页码：1636 / 1641

页数：6

相关论文

共 38 条

[1] The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse [J].

Bachas, C. ;

Schuurhuis, G. J. ;

Assaraf, Y. G. ;

Kwidama, Z. J. ;

Kelder, A. ;

Wouters, F. ;

Snel, A. N. ;

Kaspers, G. J. L. ;

Cloos, J. .

LEUKEMIA, 2012, 26 (06) :1313-1320

[2] Molecular genetics in acute myeloid leukemia [J].

Bacher, Ulrike ;

Schnittger, Susanne ;

Haferlach, Torsten .

CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) :646-655

[3] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[4] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia [J].

Buccisano, Francesco ;

Maurillo, Luca ;

Del Principe, Maria Ilaria ;

Del Poeta, Giovanni ;

Sconocchia, Giuseppe ;

Lo-Coco, Francesco ;

Arcese, William ;

Amadori, Sergio ;

Venditti, Adriano .

BLOOD, 2012, 119 (02) :332-341

[5] Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype [J].

Cazzaniga, G ;

Dell'Oro, MG ;

Mecucci, C ;

Giarin, E ;

Masetti, R ;

Rossi, V ;

Locatelli, F ;

Martelli, MF ;

Basso, G ;

Pession, A ;

Biondi, A ;

Falini, B .

BLOOD, 2005, 106 (04) :1419-1422

[6] Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia [J].

Cristobal, Ion ;

Garcia-Orti, Laura ;

Cirauqui, Cristina ;

Cortes-Lavaud, Xabier ;

Garcia-Sanchez, Maria A. ;

Calasanz, Maria J. ;

Odero, Maria D. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (04) :543-550

[7] A basis for updating our approach to resistant acute leukemia [J].

Cunningham, Isabel .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) :251-257

[8] Beyond morphology: minimal residual disease detection in acute myeloid leukemia [J].

DiNardo, Courtney D. ;

Luger, Selina M. .

CURRENT OPINION IN HEMATOLOGY, 2012, 19 (02) :82-88

[9] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[10] Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics [J].

Gaidzik, Verena ;

Doehner, Konstanze .

SEMINARS IN ONCOLOGY, 2008, 35 (04) :346-355

← 1 2 3 4 →